https://commons.ru.ac.za/vital/access/manager/Index en-us 5 In vitro diffusion cell design and validation. I. A stability-indicating high-performance liquid chromatographic assay for betamethasone 17-valerate in purified isopropyl myristate receptor phase https://commons.ru.ac.za/vital/access/manager/Repository/vital:6431 Tue 14 May 2024 12:45:06 SAST ]]> In vitro diffusion cell design and validation. II. Temperature, agitation and membrane effects on betamethasone 17-valerate permeation https://commons.ru.ac.za/vital/access/manager/Repository/vital:6422 Tue 14 May 2024 12:42:56 SAST ]]> Ranking of topical corticosteroids: principles and results https://commons.ru.ac.za/vital/access/manager/Repository/vital:6434 Tue 14 May 2024 12:42:12 SAST ]]> The selection and use of natural and synthetic membranes for in vitro diffusion experiments https://commons.ru.ac.za/vital/access/manager/Repository/vital:6379 Tue 14 May 2024 12:41:53 SAST ]]> In vitro release of propranolol hydrochloride from topical vehicles https://commons.ru.ac.za/vital/access/manager/Repository/vital:6435 Tue 14 May 2024 12:41:31 SAST ]]> The effects of elevated and ambient temperature conditions on dilutions of fluocinolone acetonide ointment assessed using the human skin-blanching assay https://commons.ru.ac.za/vital/access/manager/Repository/vital:6380 Tue 14 May 2024 12:41:05 SAST ]]> The human skin-blanching assay for in vitro topical corticosteroid assessment. I. Reproducibility of the assay https://commons.ru.ac.za/vital/access/manager/Repository/vital:6381 Tue 14 May 2024 12:39:53 SAST ]]> The use of supersaturated solutions for the percutaneous delivery of rooperol tetra-acetate https://commons.ru.ac.za/vital/access/manager/Repository/vital:6340 Tue 14 May 2024 12:39:15 SAST ]]> The requirements for accurate analysis of pharmaceutical research at South African Universities https://commons.ru.ac.za/vital/access/manager/Repository/vital:6367 Tue 14 May 2024 12:38:47 SAST ]]> New developments in the methodology available for the assessment of topical corticosteroid-induced skin blanching https://commons.ru.ac.za/vital/access/manager/Repository/vital:6384 Tue 14 May 2024 12:37:59 SAST ]]> Comparison of visual CR-200 and CR-300 chromameter data obtained from the corticosteroid-induced skin-blanching assay https://commons.ru.ac.za/vital/access/manager/Repository/vital:6344 Tue 14 May 2024 12:35:42 SAST ]]> Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin https://commons.ru.ac.za/vital/access/manager/Repository/vital:6425 Tue 14 May 2024 12:33:53 SAST ]]> Analysis of chromameter results obtained from corticosteroid-induced skin blanching assay: comparison of visual and chromameter data https://commons.ru.ac.za/vital/access/manager/Repository/vital:6426 Tue 14 May 2024 12:33:28 SAST ]]> Quantification of corticosteroid-induced skin vasoconstriction: visual ranking, chromameter measurement or digital image analysis https://commons.ru.ac.za/vital/access/manager/Repository/vital:6427 Tue 14 May 2024 12:32:38 SAST ]]> Foam drug delivery in dermatology: beyond the scalp https://commons.ru.ac.za/vital/access/manager/Repository/vital:6418 Tue 14 May 2024 12:32:15 SAST ]]> Role of percutaneous penetration enhancers https://commons.ru.ac.za/vital/access/manager/Repository/vital:6446 Tue 14 May 2024 12:13:49 SAST ]]> Analysis of chromameter results obtained from corticosteroid-induced skin blanching. I. Manipulation of data https://commons.ru.ac.za/vital/access/manager/Repository/vital:6424 Tue 14 May 2024 12:12:30 SAST ]]> Application of the Minolta chromameter to the assessment of corticosteroid-induced skin blanching https://commons.ru.ac.za/vital/access/manager/Repository/vital:6451 Tue 14 May 2024 12:10:50 SAST ]]> The human skin blanching assay for in vivo topical corticosteroid assessment. II. Subject- and observer-dependent variation in blanching responses https://commons.ru.ac.za/vital/access/manager/Repository/vital:6382 Tue 14 May 2024 10:45:44 SAST ]]> Evaluation of the proposed FDA pilot-dose response methodology for topical corticosteroid bioeqivalence testing [authors' reply in Letters to the Editor] https://commons.ru.ac.za/vital/access/manager/Repository/vital:6423 Tue 14 May 2024 10:44:40 SAST ]]>